TrialFrontiers in immunology2022

Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients.

Changju Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.